Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS · Delayed Price · Currency is USD
0.1831
0.00 (0.00%)
Sep 16, 2026, 4:00 PM EST
Ampio Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 | Jun '19 Jun 30, 2019 | Mar '19 Mar 31, 2019 |
Selling, General & Admin | 7.08 | 8.07 | 9.97 | 12 | 11.47 | 14 | 12.28 | 10.43 | 8.67 | 5.95 | 6.34 | 6.42 | 6.66 | 6.55 | 6.65 | 6.61 | 5.95 | 5.35 | 4.36 | 3.94 |
Research & Development | 2.44 | 1.94 | 4.35 | 5.75 | 8.92 | 12.91 | 12.76 | 13.29 | 11.9 | 9.31 | 8.37 | 7.21 | 9.17 | 12.52 | 14.29 | 15.31 | 12.62 | 8.61 | 6.37 | 6.35 |
Operating Expenses | 9.52 | 10 | 14.33 | 17.76 | 20.38 | 26.91 | 25.04 | 23.72 | 20.57 | 15.25 | 14.7 | 13.63 | 15.83 | 19.07 | 20.94 | 21.92 | 18.58 | 13.97 | 10.74 | 10.29 |
Operating Income | -9.52 | -10 | -14.33 | -17.76 | -20.38 | -26.91 | -25.04 | -23.72 | -20.57 | -15.25 | -14.7 | -13.63 | -15.83 | -19.07 | -20.94 | -21.92 | -18.58 | -13.97 | -10.74 | -10.29 |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0 | -0.01 | -0.01 |
Interest & Investment Income | 0.35 | 0.38 | 0.39 | 0.32 | 0.22 | 0.12 | 0.04 | 0.01 | 0 | 0 | 0 | 0 | 0.01 | 0.04 | 0.04 | 0.06 | 0.08 | 0.05 | 0.05 | 0.02 |
Other Non Operating Income (Expenses) | 0.31 | 0.59 | 1.67 | 4.46 | 5.76 | 8.39 | 7.44 | 4.67 | 3.49 | -0.22 | -0.43 | -1.22 | -0.54 | 6.27 | 4.2 | 8.86 | 4.87 | 2.95 | 12.75 | 16.52 |
EBT Excluding Unusual Items | -8.87 | -9.03 | -12.28 | -12.98 | -14.4 | -18.41 | -17.56 | -19.04 | -17.08 | -15.47 | -15.13 | -14.85 | -16.37 | -12.77 | -16.69 | -13 | -13.63 | -10.96 | 2.06 | 6.26 |
Gain (Loss) on Sale of Assets | -0.06 | -0.06 | -0.06 | -0.06 | - | - | - | - | - | - | -0.07 | -0.07 | -0.07 | -0.07 | - | - | - | -0.12 | -0.12 | -0.12 |
Asset Writedown | - | - | -1.94 | -1.94 | -1.94 | -1.94 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Other Unusual Items | 0.29 | 0.29 | 0.29 | 0.29 | - | - | - | - | - | - | - | 0.54 | 0.54 | 0.54 | 0.54 | - | - | - | - | - |
Pretax Income | -8.63 | -8.8 | -13.98 | -14.68 | -16.34 | -20.34 | -17.56 | -19.04 | -17.08 | -15.47 | -15.21 | -14.38 | -15.89 | -12.3 | -16.15 | -13 | -13.63 | -11.08 | 1.94 | 6.13 |
Earnings From Continuing Operations | -8.63 | -8.8 | -13.98 | -14.68 | -16.34 | -20.34 | -17.56 | -19.04 | -17.08 | -15.47 | -15.21 | -14.38 | -15.89 | -12.3 | -16.15 | -13 | -13.63 | -11.08 | 1.94 | 6.13 |
Net Income to Company | -8.63 | -8.8 | -13.98 | -14.68 | -16.34 | -20.34 | -17.56 | -19.04 | -17.08 | -15.47 | -15.21 | -14.38 | -15.89 | -12.3 | -16.15 | -13 | -13.63 | -11.08 | 1.94 | 6.13 |
Net Income | -8.63 | -8.8 | -13.98 | -14.68 | -16.34 | -20.34 | -17.56 | -19.04 | -17.08 | -15.47 | -15.21 | -14.38 | -15.89 | -12.3 | -16.15 | -13 | -13.63 | -11.08 | 1.94 | 6.13 |
Net Income to Common | -8.63 | -8.8 | -13.98 | -14.68 | -16.34 | -20.34 | -17.56 | -19.04 | -17.08 | -15.47 | -15.21 | -14.38 | -15.89 | -12.3 | -16.15 | -13 | -13.63 | -11.08 | 1.94 | 6.13 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Shares Change (YoY) | 7.50% | 7.52% | 5.50% | 9.27% | 10.30% | 13.37% | 13.24% | 13.76% | 18.58% | 18.44% | 21.85% | 27.59% | 31.81% | 15.66% | 9.29% | 28.31% | 18.20% | 66.66% | 81.99% | 54.94% |
EPS (Basic) | -10.66 | -11.12 | -18.54 | -19.47 | -21.68 | -27.63 | -24.56 | -27.60 | -25.70 | -23.82 | -24.09 | -23.72 | -27.59 | -22.43 | -31.17 | -27.35 | -31.31 | -23.38 | 4.08 | 16.56 |
EPS (Diluted) | -10.66 | -11.59 | -20.50 | -25.28 | -29.32 | -39.02 | -34.97 | -34.38 | -30.10 | -23.82 | -24.09 | -23.72 | -27.59 | -32.19 | -39.28 | -39.88 | -42.32 | -23.38 | 4.08 | 16.56 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 | Jun '19 Jun 30, 2019 | Mar '19 Mar 31, 2019 |
Free Cash Flow | -8.56 | -10.55 | -15.94 | -18.49 | -21.13 | -20.54 | -18.52 | -14.9 | -14.19 | -13.38 | -12.21 | -14.47 | -14.79 | -16.66 | -18.64 | -17.51 | -15.41 | -13.05 | -11.57 | -11.36 |
Free Cash Flow Per Share | -10.57 | -13.33 | -21.13 | -24.52 | -28.04 | -27.90 | -25.91 | -21.60 | -20.76 | -20.60 | -19.33 | -23.86 | -25.67 | -30.38 | -35.98 | -36.85 | -35.24 | -27.53 | -24.40 | -30.66 |
EBITDA | -9.39 | -9.69 | -13.66 | -16.84 | -19.33 | -25.78 | -23.99 | -22.66 | -19.48 | -14.13 | -13.55 | -12.46 | -14.66 | -17.89 | -19.73 | -20.72 | -17.3 | -12.68 | -9.42 | -8.94 |
D&A For EBITDA | 0.13 | 0.32 | 0.66 | 0.92 | 1.05 | 1.13 | 1.04 | 1.06 | 1.09 | 1.12 | 1.15 | 1.18 | 1.18 | 1.18 | 1.21 | 1.2 | 1.27 | 1.29 | 1.31 | 1.35 |
EBIT | -9.52 | -10 | -14.33 | -17.76 | -20.38 | -26.91 | -25.04 | -23.72 | -20.57 | -15.25 | -14.7 | -13.63 | -15.83 | -19.07 | -20.94 | -21.92 | -18.58 | -13.97 | -10.74 | -10.29 |